SFX by Ex Libris Inc.

Title:	Modelling Myc inhibition as a cancer therapy
Source:	Nature [0028-0836] Soucek, L yr:2008

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Phuoc T. Tran et al.;, Dean W W. "Combined Inactivation of MYC and K-Ras Oncogenes Reverses Tumorigenesis in Lung Adenocarcinomas and Lymphomas." PLOS One 3.5 (2008).
description	2.	Ponzielli, R. "Cancer therapeutics: Targeting the dark side of Myc." European journal of cancer 41.16 (2005): 2485-2501.
description	3.	Martins, Carla P P. "Modeling the therapeutic efficacy of p53 restoration in tumors." Cell 127.7 (2007): 1323-34.
description	4.	Evan, G. "Cellular senescence: hot or what?" Current opinion in genetics & development 19.1 (2009): 25-31.
description	5.	Gotvajn, Andreja Z. "Pretreatment of highly polluted pharmaceutical waste broth by wet air oxidation." Journal of environmental engineering 133.1 (2007): 89-94.
description	6.	Ben-Porath, I. "The signals and pathways activating cellular senescence." The international journal of biochemistry & cell biology 37.5 (2005): 961-976.
description	7.	Ventura, A. "Restoration of p53 function leads to tumour regression in vivo." Nature 445.7128 (2007): 661-665.
description	8.	Lowe, Wen W. "Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas." Nature 445.7128 (2006): 656-60.
description	9.	Ferreira, C. "Developmental phases of individual mouse preimplantation embryos characterized by lipid signatures using desorption electrospray ionization mass spectrometry." Analytical and bioanalytical chemistry 404.10 (2012): 2915-2926.
description	10.	Bavi, R. "The biological and clinical impact of inhibition of NF??B initiated apoptosis in diffuse large B?cell lymphoma (DLBCL)." The Journal of pathology 224.3 (2011): 355-366.
description	11.	Fukazawa, T. "Inhibition of Myc effectively targets KRAS mutation-positive lung cancer expressing high levels of Myc." Anticancer research 30.10 (2010): 4193-4200.
description	12.	Lloyd, A C C. "Lack of replicative senescence in normal rodent glia." Science 291.5505 (2001): 872-5.
description	13.	TOMLINSON, A. "CELL FATE IN THE DROSOPHILA OMMATIDIUM." Developmental biology 123.1 (1987): 264-275.
description	14.	Berg, T. "Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts." Proceedings of the National Academy of Sciences of the United States of America 99.6 (2002): 3830-3835.
description	15.	Ciampolillo, A. "The IGF-I/IGF-I receptor pathway: Implications in the pathophysiology of thyroid cancer." Current medicinal chemistry 12.24 (2005): 2881-2891.
description	16.	Dang, Chi V V. "The great MYC escape in tumorigenesis." Cancer cell 8.3 (2005): 177-8.
description	17.	Dunker, Zoran K. "Intrinsic disorder and protein function." Biochemistry 41.21 (2002): 6573-6582.
description	18.	Lowe, S W W. "Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a." Cell 88.5 (1997): 593-602.
description	19.	Lei, Y J. "A study on ruthenium-based catalysts for pharmaceutical wastewater treatment." Water science and technology 64.1 (2011): 117-121.
description	20.	Kefala, AI I. "Biosorption of cadmium ions by Actinomycetes and separation by flotation." Environmental pollution 104.2 (1999): 283-293.